رجوع
نطاق اليوم
KWD 0.65
KWD 0.65
نطاق 52 أسبوعًا
KWD 0.65
KWD 0.65
حجم التداول
400
متوسط 50 يوم / 200 يوم
KWD 0.65
/
KWD 0.65
الإغلاق السابق
KWD 0.65
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 10.6 | 0.4 |
| P/B | 1.0 | 2.9 |
| ROE % | 9.6 | 3.7 |
| Net Margin % | 26.3 | 3.8 |
| Rev Growth 5Y % | -0.7 | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Revenue declined -0.65% annually over 5 years
Earnings declined -20.74% over the past year
Net margin of 26.25% shows strong profitability
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -260.42M
P/E of 10.64 — trading at a low valuation
النمو
Revenue Growth (5Y)
-0.65%
Revenue (1Y)-87.94%
Earnings (1Y)-20.74%
FCF Growth (3Y)N/A
الجودة
Return on Equity
9.61%
ROIC8.23%
Net Margin26.25%
Op. Margin31.29%
الأمان
Debt / Equity
0.03
Current Ratio19.65
Interest Coverage83.67
التقييم
P/E Ratio
10.64
P/B Ratio1.01
EV/EBITDA4.48
Dividend Yield0.07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -87.94% | Revenue Growth (3Y) | -0.23% |
| Earnings Growth (1Y) | -20.74% | Earnings Growth (3Y) | -69.27% |
| Revenue Growth (5Y) | -0.65% | Earnings Growth (5Y) | -10.05% |
| Profitability | |||
| Revenue (TTM) | 194.41M | Net Income (TTM) | 51.03M |
| ROE | 9.61% | ROA | 8.52% |
| Gross Margin | 61.16% | Operating Margin | 31.29% |
| Net Margin | 26.25% | Free Cash Flow (TTM) | -260.42M |
| ROIC | 8.23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 19.65 |
| Interest Coverage | 83.67 | Dividend Yield | 0.07% |
| Valuation | |||
| P/E Ratio | 10.64 | P/B Ratio | 1.01 |
| P/S Ratio | 2.79 | PEG Ratio | -0.12 |
| EV/EBITDA | 4.48 | Dividend Yield | 0.07% |
| Market Cap | 542.78M | Enterprise Value | 272.84M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 194.41M | 1.61B | 195.29M | 221.60M | 199.55M |
| Net Income | 51.03M | 64.38M | 540.39M | 82.68M | 77.94M |
| EPS (Diluted) | 0.06 | 0.60 | 0.08 | 0.10 | 0.09 |
| Gross Profit | 118.90M | 1.07B | 134.12M | 139.02M | 142.53M |
| Operating Income | 60.84M | 576.92M | 79.93M | 103.97M | 98.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 598.72M | 586.72M | 567.74M | 543.45M | 494.82M |
| Total Liabilities | 37.49M | 40.29M | 52.97M | 64.85M | 40.95M |
| Shareholders' Equity | 537.98M | 524.42M | 495.03M | 461.41M | 438.31M |
| Total Debt | 16.26M | 15.89M | 16.88M | 13.20M | 16.47M |
| Cash & Equivalents | 286.19M | 228.29M | 128.04M | 254.86M | 212.90M |
| Current Assets | 522.16M | 510.31M | 492.32M | 471.47M | 420.19M |
| Current Liabilities | 26.57M | 235.35M | 42.24M | 53.58M | 27.32M |